5%+ stake

Collegium Pharmaceutical, Inc. (COLL): FULLER & THALER ASSET MANAGEMENT, INC. cut its COLL stake below 5% (1.8%) 1.8%

FULLER & THALER ASSET MANAGEMENT, INC. cut its COLL stake below 5% (1.8%).

1.8%
Stake
599K
Shares owned
Stake as of
Sep 30, 2026
Filed
Nov 16, 2026

What stands out in this filing

  • Reported stake 1.8% (598,540.14 shares).
  • The filing reports the stake below 5%, the level at which these reports stop being required.
  • A 13G is the short form for a passive owner of more than 5%.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 6, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors

What came next

  1. Oct 8, 20265% stakeMillennium Management LLC reported a passive stake (13G) of 7.4%
  2. Oct 15, 2026Company filing · Form 8-K · Agreement endedEnded an important agreement
  3. Oct 29, 20265% stakePRINCIPAL GLOBAL INVESTORS reported a passive stake (13G) of 4.7%
  4. Oct 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 5.0%
  5. Nov 5, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  6. Nov 10, 20265% stakeSTATE STREET CORPORATION reported a passive stake (13G) of 5.4%
  7. Nov 10, 20265% stakeInvesco Ltd. reported a passive stake (13G) of 3.9%
  8. Nov 16, 20265% stakeJANUS HENDERSON GROUP Ltd. reported a passive stake (13G) of 0.2%
  9. Nov 16, 20265% stakeFULLER & THALER ASSET MANAGEMENT, INC. reported a passive stake (13G) of 1.8%
View the official recordSEC Schedule 13G

How to read SEC Schedule 13G

A Schedule 13D and a Schedule 13G both disclose beneficial ownership of more than 5% of a US company's voting shares. A 13D is the long form, filed by holders who may seek to influence or control the company, and it must state what they intend to do. A 13G is the short form, open only to passive holders and to certain institutions holding in the ordinary course of business, and it asks no question about intent.

Full guide: Schedule 13D vs Schedule 13G: what is the difference?

What else is on file for Collegium Pharmaceutical, Inc.

For Collegium Pharmaceutical, Inc., OQRO holds 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its COLL page.

How this filing works

Explore the data

Common questions

What does this filing report about Collegium Pharmaceutical, Inc. (COLL) stock?

FULLER & THALER ASSET MANAGEMENT, INC. cut its COLL stake below 5% (1.8%). Of the company, Schedule 13G (passive).

When did it happen, and when was it made public?

Stake as of: Sep 30, 2026. Filed: Nov 16, 2026.

What stands out in this filing?

Reported stake 1.8% (598,540.14 shares). The filing reports the stake below 5%, the level at which these reports stop being required. A 13G is the short form for a passive owner of more than 5%.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Schedule 13G, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Collegium Pharmaceutical, Inc. recently?

For Collegium Pharmaceutical, Inc., OQRO holds 3 fund holdings reports (13F) dated in the last 90 days. They are listed on the COLL page.

Does this mean COLL stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Collegium Pharmaceutical, Inc.

Everything OQRO holds on this company is on its COLL page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data